Fluoroapatite glass-ceramic coating on alumina: Surface behavior with biological fluids

Journal of Biomedical Materials Research - Part A

Volumn 66, Issue 3, 2003, Pages 615-621

  Bosetti, M ^a   Verne E ^b   Brovarone, C Vitale ^b   Moisescu, C ^c   Sabbatini, M ^a   Cannas, M ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b POLITECNICO DI TORINO   (Italy)

^c NONE

Author keywords

Alumina; Complement activation; Fluoroapatite glass ceramic; Plasma protein binding; Surface behavior

Indexed keywords

ALUMINA; BODY FLUIDS; BONE; HYDROXYAPATITE; NUCLEATION; PROTEINS;

BONE INTEGRATION;

BIOMATERIALS;

ALBUMIN; ALPHA ALUMINA; ALUMINUM OXIDE; COMPLEMENT COMPONENT BB; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3C; FIBRONECTIN; FLUORAPATITE; GLASS; HYDROXYAPATITE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PLASMA PROTEIN; UNCLASSIFIED DRUG; ZYMOSAN;

ARTICLE; BINDING KINETICS; BIOCOMPATIBILITY; BIOMECHANICS; BODY FLUID; BONE TISSUE; CELL ADHESION; CELL SPREADING; CERAMIC PROSTHESIS; CERAMICS; CHEMICAL INTERACTION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CRYSTALLIZATION; EVALUATION; FLUOROAPATITE BASED GLASS CERAMIC; HUMAN; HUMAN CELL; INFLAMMATION; MATERIAL COATING; MATERIALS TESTING; MECHANICAL STRESS; PHYSICAL RESISTANCE; PROTEIN INTERACTION; QUANTITATIVE DIAGNOSIS; SIMULATION; SURFACE PROPERTY;

EID: 0344738720     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10030     Document Type: Article

References (17)

1. De Aza AH, Chevalier J, Fantozzi G, Schehl M, Torrecillas R. Crack growth resistance of alumina, zirconia, and zirconia toughened alumina ceramics for joint prostheses. Biomaterials 2002;23:937-945.
2. Hamadouche M, Meunier A, Greenspan DC, Blanchat C, Zhong JP, La Torre GP, Sedel L. Bioactivity of sol-gel bioactive glass coated alumina implants. J Biomed Mater Res 2000;52:422-429.
3. Lacefield WR. Current status of ceramic coatings for dental implants. Implant Dent 1998;7:315-322.
4. 2 substrates in vitro. J Biomed Mater Res 1999;44:12-21.
5. 2 system. J Biomed Mater Res 1999;47:243-250.
6. Bosetti M, Vernè E, Ferraris M, Ravaglioli A, Carmas M. In vitro characterization of zirconia coated by bioactive glass. Biomaterials 2001;22:987-994.
7. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-734.
8. Vernè E, Bosetti M, Vitale Bovarone C, Moisescu C, Lupo F, Spriano S, Cannas M. Fluoroapatite glass-ceramic coatings on alumina: Structural, mechanical, and biological characterization. Biomaterials 2002;23:2395-2403.
9. Scotchford CA, Gilmore CP, Cooper E, Leggett GJ, Downes S. Protein adsorption and human osteoblast-like cell attachment and growth on alkylthiol on gold self-assembled monolayers. J Biomed Mater Res 2002;59:84-99.
10. DeHeer DH, Engels JA, DeVries AS, Knapp RH, Beebe JD. In situ complement activation by polyethylene wear debris. J Biomed Mater Res 2001;54:12-19.
11. Tengvall P, Askendal A, Lundstrom I. Temporal studies on the deposition of complement on human colostrum IgA and serum IgG immobilized on methylated silicon. J Biomed Mater Res 1997;35:81-92.
12. Jana C, Braun M. 19F NMR spectroscopy of glass ceramics containing fluorapatites. Biomaterials. 1996;17(21):2065-2069.
13. Underwood PA, Steele JG, Dalton BA. Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin analyzed with monoclonal antibodies. J Cell Sci 1993;104:793-803.
14. Chintalacharuvu KR, Vuong LU, Loi LA, Larrick JW, Morrison SL. Hybrid IgA2/IgG1 antibodies with tailor-made effector functions. Clin Immunol 2001;101(1):21-31.
15. Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis. Am J Kidney Dis 2001;38(5):1082-1088.
16. Wettero J, Bengtsson T, Tengvall P. Complement activation on immunoglobulin G-coated hydrophobic surfaces enhances the release of oxygen radicals from neutrophils through an actin-dependent mechanism. J Biomed Mater Res 2000;51:742-751.
17. Rinder CS, Rinder HM, Johnson K, Smith M, Lee DL, Tracey J, Polack G, Higgins P, Yeh CG, Smith BR. Role of C3 cleavage in monocyte activation during extracorporeal circulation. Circulation 1999;100:553-558.